Speaker Profile
Karin Hehenberger

Karin Hehenberger PhD, MD

Biotechnology, Pharmacy and Medicine, Nuclear Pharmacy, Endocrinology, Metabolism and Diabetes
New York, New York, United States of America

Connect with the speaker?

Dr. Hehenberger, MD, PhD is a leading medical and business expert in the biopharmaceutical industry and has more than 15 years of experience in leadership positions at JNJ, Eyetech pharmaceuticals, Coronado biosciences, and also as an investment professional at two large funds, Brummer and partners and Scandinavian Life Science Ventures.

Her dedication to diabetes is reflected by her time on the senior team at the JDRF and conducting her post-doctorate at the Joslin Diabetes Center, Harvard Medical School.

She received her MD and PhD at the Karolinska Institute in Stockholm, Sweden, where she retains a position with the Department of Endocrinology and Surgery. In 2014, she co-founded Lyfebulb, together with Mr Riccardo Braglia, CEO Helsinn and Dr Stephen Squinto, Venture partner Orbimed.
EVENTS & ACTIVITIES (Speaking, Spoken, and Authored)